Last update:
Clinical pharmacology news
Inspired by 'Flowers for Algernon,' experimental nose drops improve memory in mice
Researchers at the University of Sydney have developed experimental nose drops that enhance learning and memory in aged mice while also preventing memory loss in a mouse model of Alzheimer's disease. The treatment uses mRNA ...
46 minutes ago
0
0
Chewable fish oil emulsion supplements may be better than soft-gel capsules
In a crossover clinical trial published in the European Journal of Lipid Science and Technology, investigators found that a chewable fish oil emulsion supplement may provide higher circulating levels of omega-3 fatty acids ...
2 hours ago
0
0
Tirzepatide moves more than half of treated teens below obesity threshold, new clinical trial reports
Tirzepatide (Zepbound) is a once-weekly injectable medication that hits two targets at once. This dual-action drug mimics the effects of two natural gut hormones in the body—glucose-dependent insulinotropic polypeptide (GIP) ...
First successful human challenge model for dengue serotype 4 could speed vaccine and drug testing
Researchers at the University of Maryland School of Medicine (UMSOM) and the Institute of Human Virology (IHV) have developed the first successful human challenge model for dengue serotype 4, a major advance that could speed ...
13 hours ago
0
3
GLP-1 weight-loss drugs linked to inadequate intake of key nutrients in some people
Drugs taken to suppress appetite, such as Wegovy and Mounjaro, are associated with inadequate intakes of key nutrients and energy in some people, finds a small exploratory study published in the journal BMJ Nutrition Prevention ...
11 hours ago
0
8
Psilocybin may improve a difficult-to-treat symptom of depression, study finds
New research from the University of Colorado Anschutz suggests that psilocybin may help improve anhedonia, the loss of interest or ability to experience pleasure, in people with treatment-resistant depression. In a clinical ...
7 hours ago
0
2
FDA approves first factor XIa inhibitor for secondary stroke prevention
The U.S. Food and Drug Administration has approved Sunharbo (asundexian) 50 mg tablets, in combination with antiplatelet therapy, to reduce the risk for stroke in adults following a recent mild-to-moderate noncardioembolic ...
8 hours ago
0
3
First evidence from a Chinese population supports review of long-term blood monitoring for local clozapine use
An international research team led by the Department of Psychiatry, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has completed a long-term population-based research study to ...
11 hours ago
0
3
For military veterans with PTSD and alcohol use disorder, MDMA-assisted therapy may be safe, effective
The first study of a program that uses the drug MDMA to treat post-traumatic stress disorder (PTSD) plus alcohol use disorder in military veterans has concluded with promising results.
12 hours ago
0
3
Five things that shape body weight—by an obesity expert
What you eat when you're tired and hungry might come down to what's open on the way home and what you can afford. Both appetite and access to food shape decisions that can look, from the outside, like simple matters of choice.
15 hours ago
0
5
Increasing methadone doses associated with improved quality of life
The introduction of fentanyl, a potent synthetic opioid, into the U.S. drug supply has remade the landscape for health and recovery. This includes changing norms around the use of methadone, a common treatment option for ...
19 hours ago
0
11
New SARS-CoV-2 variant PJ.2.1: Vaccine antibodies provide protection
Germany's COVID-19 traffic light is red, and the number of infections is high. But how well is the population protected against the virus variants currently circulating? The new SARS-CoV-2 variant PJ.2.1 has been spreading ...
20 hours ago
0
3
Researchers find potential way to protect the brain from HIV and opioid damage
People living with HIV continue to struggle with memory loss, difficulty concentrating and poor decision-making, even as antiretroviral treatments have dramatically improved life expectancy. For patients who also use opioids—which ...
Nov 16, 2026
0
44
HIV drug lenacapavir found to disrupt virus formation, creating giant noninfectious particles
Lenacapavir is a powerful, long-acting drug used to prevent and treat HIV infection. While it is known to block key steps in the virus's replication after entering a cell, researchers have now uncovered another way the drug ...
Nov 16, 2026
0
14
This time, the virus is on the patient's side. AI helped design it
AI can write emails, create seasoning blends or put pets in Renaissance outfits. One adventurous baker used ChatGPT to concoct a cake from sauerkraut and seaweed. Now, there's an AI-made virus on the scene.
Nov 16, 2026
0
11
Ending Medicaid coverage for weight-loss drugs linked to sharp drop in GLP-1 use
Medicaid prescriptions for weight loss–approved GLP-1 medications fell sharply after four states ended coverage of the drugs, according to a new study led by researchers at the University of Pittsburgh. The findings, published ...
Nov 16, 2026
0
15
Weekly weight-loss injection combo shows promise
Two lower doses of CagriSema, a weekly injection combining two appetite-reducing medicines, cagrilintide and semaglutide, led to substantial weight loss in adults with obesity or with overweight and a weight-related health ...
Nov 16, 2026
0
48
Astaxanthin supplements: What the science says about skin, exercise and your brain
Smoother skin, sharper eyesight, better memory, stronger joints, improved athletic performance and even protection against aging—astaxanthin is marketed as a supplement with an extraordinary range of health benefits. But ...
Nov 16, 2026
0
8
A cancer drug is being touted online as a way to grow taller—what you need to know
A cancer drug linked to rapid growth spurts in children has caught the attention of teenagers looking to gain an extra few inches in height.
Nov 16, 2026
0
7
What's the link between ADHD medication and psychosis?
This year, several alarming reports have warned that Australians are developing psychosis from using stimulant medications, typically prescribed for attention deficit hyperactivity disorder, or ADHD.
Nov 16, 2026
0
7
Beyond DMT: Why the true power of Brazil's sacred jurema plant is social, not just psychedelic
Jurema-preta is the name of both a plant—Mimosa tenuiflora—and an Indigenous spiritual tradition of northeastern Brazil. The plant is used to make a potentially hallucinogenic brew that is consumed in sacred rituals. The ...
Nov 16, 2026
0
4
A single CRISPR infusion lowers blood fats in monkeys for three years
High levels of LDL cholesterol and triglycerides, which are types of blood fats, are major contributors to atherosclerotic cardiovascular disease. Gene-editing technologies offer a potential alternative to lipid-lowering ...
Hepatitis B: Controlling the virus does not mean a cure
Having a vaccine available is essential for preventing hepatitis B, but it is not enough when part of the population cannot access it.
Nov 14, 2026
0
9
A microbe-made molecule may reverse gut damage by boosting NAD levels
Scientists at Rutgers Health have discovered a molecule produced by "good" gut bacteria that rapidly heals the intestinal lining, protecting against severe inflammatory diseases and triggering increased production of a coenzyme ...
Nov 13, 2026
0
383
GLP-1s often contain untested additive combinations, study finds
Use of GLP-1 receptor agonist medications (GLP-1s) has skyrocketed in recent years, and many people are using "compounded" GLP-1 products: medicines that include GLP-1s as well as other active substances, some of which are ...
Nov 13, 2026
0
88
























